查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2002786

外骨骼機器人市場：2026-2032年全球市場預測（依產品類型、應用、最終用戶、技術和驅動系統分類）

Exoskeleton Robots Market by Product Type, Application, End User, Technology, Actuation Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外骨骼機器人市場價值將達到 14.6 億美元，到 2026 年將成長到 19.6 億美元，到 2032 年將達到 122.6 億美元，複合年成長率為 35.46%。

主要市場統計數據
基準年 2025 14.6億美元
預計年份：2026年 19.6億美元
預測年份 2032 122.6億美元
複合年成長率 (%) 35.46%

外骨骼機器人全面介紹：本文說明了外骨骼機器人的功能、各種應用案例以及在現實世界環境中部署所需的跨學科整合。

外骨骼機器人融合了機械工程、控制系統、感測器和人體工學，旨在增強、恢復或提升人類的身體功能。其應用範圍涵蓋被動支撐框架到完全驅動系統，後者可提供外部動力和控制，以輔助運動、重新分配負荷或提高耐力。隨著這項技術從專業研究機構走向商業和國防領域，相關人員不僅要考慮技術性能，還必須考慮法律規範、臨床檢驗以及在複雜工作環境中的運作整合。

材料、感測器、軟體和經營模式的快速發展如何改變外骨骼機器人在工業、醫療和國防領域的部署。

外骨骼生態系統正經歷一系列變革性變化，這些變化正在重塑其價值提案和應用路徑。輕質複合材料和緊湊型高能量密度電池的進步，在減輕設備重量的同時延長了運作時間，從而提高了用戶接受度並拓展了實際應用範圍。同時，感測器、嵌入式控制演算法和邊緣人工智慧的進步，使得人機意圖識別更加流暢，降低了動態工作中的認知負荷，並提高了安全性。

評估美國2025年關稅措施的變化將如何重塑外骨骼產業的供應鏈、籌資策略和採購趨勢。

美國2025年的關稅政策正在對外骨骼製造至關重要的全球供應鏈帶來巨大衝擊，並對籌資策略、零件成本和進度風險產生連鎖反應。對某些進口子組件和電子元件徵收的關稅降低了單一產地採購的吸引力，促使製造商重新考慮供應商多元化和近岸外包方案。為此，許多原始設備製造商 (OEM) 和目的地契約製造正在其他地區啟動供應商認證計劃，以降低關稅風險並維持關鍵零件（例如執行器、電力電子元件和感測器）的供應連續性。

詳細的細分分析揭示了產品類型、應用、最終用戶、技術和驅動系統如何決定獨特的設計和商業化路徑。

細分市場分析揭示了產品架構、應用重點、最終用戶需求、技術選擇和驅動系統偏好方面的關鍵差異，這些差異影響著設計優先順序和市場策略。根據產品類型，設計人員區分了旨在增強全身功能以應對重體力勞動的「全身系統」、專注於步態輔助和復健的「下肢解決方案」以及提供精細運動支持和治療性介入的「上肢設備」。根據應用領域，相關人員必須在不同的使用情境中權衡不同的性能和監管標準：例如，在國防領域（如炸彈處理、貨物搬運和士兵能力提升）的部署；在工業環境中（包括製造、物料輸送和倉儲管理）；在醫療環境中（涵蓋康復、手術輔助和治療，其中康復又細分為援助訓練和物理治療）；

區域趨勢與策略考量：美洲、歐洲、中東和非洲以及亞太地區如何開闢各自的商業性和機構採用之路。

區域趨勢影響著監管預期、人才引進和採購行為，最終影響部署策略和夥伴關係模式。在美洲，先進的工業自動化項目、雄厚的國防採購預算以及以價值為導向的醫療保健產業共同推動了部署。在該地區運營的公司通常優先考慮穩健的設計、與現有工業安全計劃的整合以及創建符合支付方要求的臨床證據。在歐洲、中東和非洲，監管和商業環境則更為多樣化。西方市場優先考慮臨床標準和工人保護規範，中東市場通常優先考慮為國防和基礎設施計劃快速獲取產能，而非洲部分地區則出現了與特定工業現代化舉措和國際援助醫療保健項目相關的新興需求。

製造商和服務供應商之間的關鍵競爭模式和策略立場，其特點是模組化、夥伴關係和數據驅動的資產管理。

競爭情報顯示，主要企業和新興參與企業正透過多種方式實現差異化，包括系統模組化、數據驅動的服務交付、臨床研究夥伴關係以及整合培訓生態系統。一些企業專注於單一應用領域的深厚專業知識，例如下肢復健或工業物料搬運，開發專有的控制演算法和使用者自訂系統，以縮短設定時間並改善臨床或營運效果。而另一些企業則奉行平台策略，優先考慮模組化和相容的子系統，使其能夠透過配置變更而非重新設計來適應多種最終用途。

製造商和機構買家應重點關注哪些具體戰略事項，以加速安全、擴充性且具有商業性可行性的外骨骼的部署。

產業領導者需要將技術創新與切實可行的部署策略結合，以加速產品普及化並管控風險。首先，應優先考慮互通性和模組化設計，使設備能夠針對不同的應用場景進行配置，而無需進行客製化的重新設計。這可以縮短部署時間並擴大目標市場。其次，應投資嚴格的臨床和運行檢驗項目，以產生可靠的結果指標。此類證據對於在工業安全領域進行報銷談判和推廣應用至關重要。第三，應儘早建立服務和培訓框架，因為對於許多買家而言，計算總擁有成本 (TCO) 取決於可預測的維護、使用者部署支援和及時的技術支援。

我們採用透明、多方面的研究途徑，結合初步訪談、技術檢驗、供應鏈分析和競爭情報分析，為高度自信的決策提供支援。

本調查方法融合了多種定性和定量方法，旨在全面深入地理解技術、監管和商業性趨勢。主要研究包括對國防、工業和醫療領域的工程師、臨床醫生、採購負責人和最終用戶進行結構化訪談，以識別營運限制和推廣障礙。輔助資訊包括同儕審查的臨床出版刊物、專利申請和政府採購文件，檢驗技術主張和監管趨勢。

簡要概述強調需要整合技術、臨床和籌資策略，才能將外骨骼從試點階段過渡到營運項目。

外骨骼機器人正從實驗性設備轉變為實用工具，在行動能力、復健和員工保護方面帶來可衡量的益處。這項轉變需要的不僅是硬體的漸進式改進；它需要一項綜合策略，將技術選擇與臨床證據、採購結構和當地監管實際情況結合。透過採用系統導向的觀點，涵蓋產品模組化、服務準備和供應鏈彈性，企業可以降低部署風險，並提高實現預期結果的可能性，例如降低受傷率、改善患者康復流程或增強營運能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外骨骼機器人市場：依產品類型分類

  • 全身型
  • 下肢
  • 上肢

第9章：外骨骼機器人市場：依應用領域分類

  • 防禦
    • 未爆彈處理
    • 貨物運輸
    • 增強士兵能力
  • 工業的
    • 製造業
    • 物料輸送
    • 倉庫管理
  • 醫療保健
    • 復原
      • 行人訓練
      • 物理治療
    • 手術支援
    • 治療
  • 個人援助
    • 日常生活支持
    • 行動支持

第10章 外骨骼機器人市場：依最終用戶分類

  • 國防組織
  • 醫院
  • 製造工廠
  • 復健中心

第11章 外骨骼機器人市場：依技術分類

  • 積極的
  • 被動的

第12章 外骨骼機器人市場（依驅動系統分類）

  • 電的
  • 油壓
  • 氣動

第13章 外骨骼機器人市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 外骨骼機器人市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 外骨骼機器人市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國外骨骼機器人市場

第17章：中國外骨骼機器人市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Bioness, Inc.
  • Bionik Laboratories Corp.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings, Inc.
  • ExoAtlet
  • Fourier Intelligence
  • Fourier Intelligence Ltd.
  • Gogoa Mobility Robots SL
  • Honda Motor Co., Ltd.
  • Hyundai Motor Company
  • INNOPHYS Co., Ltd.
  • Levitate Technologies, Inc.
  • Lockheed Martin Corporation
  • Myomo, Inc.
  • Noonee AG
  • Ottobock SE & Co. KGaA
  • Panasonic Corporation
  • Parker-Hannifin Corporation
  • ReWalk Robotics Ltd.
  • Sarcos Technology and Robotics Corporation
  • suitX
  • Technaid SL
  • Wearable Robotics Srl
Product Code: MRR-FC36D0BA9424

The Exoskeleton Robots Market was valued at USD 1.46 billion in 2025 and is projected to grow to USD 1.96 billion in 2026, with a CAGR of 35.46%, reaching USD 12.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.46 billion
Estimated Year [2026] USD 1.96 billion
Forecast Year [2032] USD 12.26 billion
CAGR (%) 35.46%

Comprehensive introduction to exoskeleton robots clarifying capabilities, use-case diversity, and the multidisciplinary integration required for real-world deployment

Exoskeleton robots are a convergence of mechanical engineering, control systems, sensors, and human factors that augment, restore, or enable human physical capabilities. They range from passive support frames to fully actuated systems that supply external power and control to assist motion, redistribute loads, or enhance endurance. As the technology moves from niche research labs into commercial and defense deployments, stakeholders must consider not only engineering performance but regulatory frameworks, clinical validation, and operational integration across complex work environments.

Adoption drivers vary by use case: in industrial settings, exoskeletons mitigate musculoskeletal injury risk and extend worker productivity; in healthcare, they facilitate rehabilitation and restore mobility; in defense, they augment soldier endurance and enable new operational concepts. The current landscape is defined by rapid prototyping cycles, iterative clinical studies, and early adopter programs that surface practical challenges such as donning/doffing times, ergonomic fit, battery life, and human-machine interface trust. Translational success increasingly depends on multidisciplinary teams combining biomechanists, occupational health experts, software engineers, and procurement leaders.

Moving forward, decision-makers should view exoskeletons not merely as end products but as systems of systems that require integrated service models, maintenance regimens, and training curricula. Strategic planning must therefore encompass lifecycle considerations, including component commonality, software update pathways, and the scalability of training and support infrastructure across distributed sites.

How rapid advances in materials, sensors, software, and commercial models are reshaping exoskeleton adoption across industrial, medical, and defense environments

The exoskeleton ecosystem is experiencing a set of transformative shifts that are reshaping value propositions and routes to deployment. Advances in lightweight composite materials and compact high-energy-density batteries are reducing device mass while extending operational endurance, which in turn improves user acceptance and expands the range of practical applications. Parallel improvements in sensors, embedded control algorithms, and edge AI enable smoother human-machine intent recognition, lowering cognitive load and improving safety during dynamic tasks.

Another critical shift is business model evolution; procurement is moving away from one-off hardware purchases toward outcome-oriented contracts, subscription services for maintenance and software updates, and managed fleet models that bundle training and analytics. This transition is reinforced by an expanding evidence base that links exoskeleton use to reduced injury rates and operational efficiencies, prompting occupational health and insurance stakeholders to consider reimbursement and incentive mechanisms. Meanwhile, regulatory frameworks are maturing unevenly across jurisdictions, with clinical pathways and conformity assessment processes becoming more defined for medical applications while industrial standards remain in active development.

Finally, cross-sector convergence is accelerating. Developments pioneered in medical rehabilitation-such as adaptive control loops and patient-specific calibration-are being translated into industrial and defense systems, while modular hardware design is enabling configurable platforms that serve multiple end uses. These shifts collectively signal a transition from proof-of-concept pilots to scalable programs, provided organizations address integration, data privacy, and workforce training requirements concurrently.

Assessment of how evolving U.S. tariff measures in 2025 are reshaping supply chains, sourcing strategies, and procurement dynamics within the exoskeleton sector

United States tariff policy in 2025 has imposed measurable friction on the global supply chains critical to exoskeleton manufacture, leading to cascading effects across sourcing strategies, component costs, and timetable risk. Tariffs on certain imported subassemblies and electronic components have reduced the attractiveness of single-origin procurement, encouraging manufacturers to reassess supplier diversification and nearshoring options. In response, many original equipment manufacturers and contract manufacturers have initiated supplier qualification programs in alternative jurisdictions to mitigate tariff exposure and maintain continuity for critical parts such as actuators, power electronics, and sensors.

Beyond direct cost implications, tariffs have altered supplier negotiation dynamics. Companies are renegotiating long-term contracts to include tariff-sharing clauses, indexed pricing mechanisms, and flexible logistics terms. Procurement teams are increasingly modeling total landed cost rather than purchase price alone, accounting for duties, longer lead times, and potential inventory holding costs associated with buffer strategies. For defense procurements, where supplier assurance and domestic content often carry strategic weight, tariffs intersect with policy incentives for local sourcing and domestic industrial base development, prompting new public-private collaboration opportunities.

Moreover, tariff-driven adjustments have accelerated technology transfer conversations and local assembly initiatives. In some cases, firms are relocating final assembly closer to major end markets to avoid tariffs on finished goods; in others, they are investing in localized component manufacturing to meet content thresholds. These operational shifts carry implications for workforce development, capital allocation, and the pace of innovation diffusion. Consequently, organizations must integrate tariff scenarios into strategic roadmaps, balancing resilience, cost, and time-to-field considerations while monitoring ongoing trade policy developments and potential administrative remedies or exemptions.

In-depth segmentation insights that clarify how product type, application, end user, technology, and actuation mode drive distinct design and commercialization pathways

Segmentation analysis reveals important distinctions in product architecture, application focus, end-user requirements, technology choice, and actuation preferences that shape both design priorities and go-to-market strategies. Based on Product Type, designers differentiate between Full Body systems that target whole-body augmentation for heavy-load tasks, Lower Limb solutions that focus on gait assistance and rehabilitation, and Upper Limb devices that enable fine motor support and therapeutic interventions. Based on Application, stakeholders must balance distinct performance and regulatory criteria across Defense deployments such as bomb disposal, load carriage, and soldier augmentation; Industrial environments including manufacturing, material handling, and warehousing; Medical settings spanning rehabilitation, surgical assistance, and therapy with rehabilitation further subdivided into gait training and physical therapy; and Personal Assistance use cases that address daily living support and mobility assistance.

Based on End User, variation in procurement behavior is evident among Defense Organizations prioritizing ruggedization and mission assurance, Hospitals emphasizing clinical validation and reimbursement pathways, Manufacturing Facilities focused on throughput and ergonomic outcomes, and Rehabilitation Centers seeking repeatable clinical protocols and long-term patient follow-up. Based on Technology, the trade-off between Active systems, which provide powered assistance and sophisticated control, and Passive systems, which offer mechanical support without powered actuation, affects device complexity, certification pathways, and maintenance demand. Based on Actuation Mode, choices among Electric, Hydraulic, and Pneumatic actuation influence system weight, responsiveness, and integration with portable power solutions.

These segmentation layers interact: for example, lower limb rehabilitation devices intended for gait training in rehabilitation centers prioritize clinical outcome measures and patient comfort, typically favoring high-fidelity active control and electric actuation, whereas industrial lower limb assist devices for material handling may opt for more robust passive or hybrid solutions to maximize durability and minimize maintenance. Consequently, strategic product roadmaps must align technical choices with the prioritized segmentation axis to ensure that development investments match end-user expectations and operational constraints.

Regional dynamics and strategic considerations showing how Americas, Europe Middle East & Africa, and Asia-Pacific each create unique pathways to commercial and institutional adoption

Regional dynamics influence regulatory expectations, talent availability, and procurement behavior in ways that materially affect deployment strategies and partnership models. In the Americas, adoption is driven by a combination of advanced industrial automation programs, strong defense procurement budgets, and a healthcare sector focused on value-based outcomes; companies operating there often prioritize ruggedized designs, integration with existing industrial safety programs, and clinical evidence generation aligned with payer requirements. Europe, Middle East & Africa present a heterogeneous regulatory and commercial environment: Western European markets emphasize clinical standards and worker protection norms, the Middle East often prioritizes rapid capability acquisition for defense and infrastructure projects, and parts of Africa manifest nascent demand tied to specific industrial modernization initiatives and international aid-funded healthcare programs.

Asia-Pacific markets combine large-scale manufacturing bases with rapidly growing healthcare investment, creating opportunities for both industrial exoskeleton deployment and medical device commercialization. Japan and South Korea lead in advanced robotics integration and user-centered design, while Southeast Asia offers scale and lower-cost manufacturing options that are attractive for contract production. China represents both supply-chain depth and a large domestic market, where local firms are advancing competitive product portfolios and where regulatory pathways are evolving to accommodate novel assistive technologies. Across regions, interoperability with local training ecosystems, localization of maintenance services, and sensitivity to labor cost dynamics will shape the pace and shape of adoption.

Strategically, regional prioritization should inform product modularity, regulatory affairs planning, and go-to-market resourcing, since success in one region often depends on adapting to local procurement cycles, reimbursement norms, and industrial standards rather than applying a single global playbook.

Key competitive patterns and strategic postures among manufacturers and service providers highlighting modularity, partnerships, and data-driven asset management

Competitive intelligence reveals that leading companies and emergent entrants are differentiating along multiple dimensions including system modularity, data-driven service offerings, clinical study partnerships, and integrated training ecosystems. Some firms emphasize deep specialization in a single application area-such as lower limb rehabilitation or industrial load carriage-developing proprietary control algorithms and user-fit systems that reduce setup time and improve clinical or operational outcomes. Others pursue platform strategies that prioritize modularity and interchangeable subsystems to serve multiple end uses through configuration rather than redesign.

Strategic partnerships between hardware providers, software developers, and occupational health or clinical institutions are increasingly common, enabling joint validation studies and accelerating time-to-adoption by generating credible evidence of safety and efficacy. Additionally, a subset of companies is investing in analytics and remote monitoring capabilities that transform exoskeletons into managed assets, allowing customers to measure usage, compliance, and outcome metrics which in turn support value-based contracting. Manufacturing strategies also vary: vertically integrated players maintain control over key components to secure supply and intellectual property, while asset-light entrants rely on contract manufacturers and focus capital on software and services.

Intellectual property positioning, standards participation, and certification roadmaps are critical competitive levers. Firms that proactively engage with standards bodies and regulatory agencies tend to shape emergent norms and reduce time-to-market barriers. For stakeholders evaluating partnerships or acquisition targets, attention should center on validated claims, service infrastructure readiness, and the ability to scale training and maintenance within customer operations.

Actionable strategic priorities for manufacturers and institutional buyers to accelerate safe, scalable, and commercially viable exoskeleton deployments

Industry leaders must align technical innovation with pragmatic deployment strategies to accelerate adoption while managing risk. First, prioritize interoperability and modularity so that devices can be configured for different use cases without bespoke redesign; this reduces time-to-deployment and broadens addressable markets. Second, invest in rigorous clinical and operational validation programs that produce defensible outcome metrics; such evidence is essential for both medical reimbursement conversations and industrial safety adoption. Third, build service and training capabilities early, as the total-cost-of-ownership calculus for many buyers hinges on predictable maintenance, user onboarding, and rapid support response.

Fourth, incorporate supply chain resilience into strategic planning by qualifying alternate suppliers, exploring nearshoring for critical components, and negotiating contracts that share tariff risk sensibly. Fifth, pursue outcome-based commercial models in pilot programs to demonstrate value before scaling and to align incentives with customers focused on productivity and injury reduction. Sixth, engage proactively with regulatory and standards bodies to inform evolving frameworks and to secure early clarity on conformity assessment pathways. Seventh, leverage partnerships with occupational health providers, rehabilitation centers, and defense research establishments to co-develop use-case specific protocols and to accelerate real-world validation.

Finally, cultivate workforce readiness through targeted training curricula and change-management programs that address worker acceptance, training cadence, and human factors. Leaders who pair technological superiority with robust support ecosystems and clear evidence of value will reduce adoption friction and capture first-mover advantages in institutional procurement cycles.

Transparent multi-method research approach combining primary interviews, technical validation, supply chain analysis, and competitive intelligence to support high-confidence decisions

The research methodology integrates multiple qualitative and quantitative approaches to provide a robust, triangulated understanding of technological, regulatory, and commercial dynamics. Primary research included structured interviews with engineers, clinical practitioners, procurement officers, and end users across defense, industrial, and medical domains to surface operational constraints and adoption barriers. Secondary sources encompassed peer-reviewed clinical literature, standards body publications, patent filings, and government procurement documents to validate technical claims and regulatory trajectories.

To analyze supply chain and tariff impacts, the methodology combined supplier mapping, bill-of-materials decomposition, and scenario-based cost-impact assessment that accounts for duties, lead times, and inventory strategies. Competitive intelligence relied on product datasheet analysis, investor presentations, and observable partnership announcements to infer strategic postures without relying on proprietary or confidential datasets. For technology assessment, bench testing protocols and expert peer review were used to verify performance claims around actuator responsiveness, battery endurance, and human-in-the-loop control stability.

Analytical rigor was enhanced through cross-validation techniques, where findings from interviews were tested against documentary evidence and independent expert review. Limitations and uncertainties were explicitly captured, and sensitivity checks were performed on key assumptions. The result is a defensible synthesis that supports decision-making while clearly delineating areas where additional primary data collection or pilot programs would reduce residual uncertainty.

Concise synthesis highlighting the necessity of integrated technical, clinical, and procurement strategies to transition exoskeletons from pilots to operational programs

Exoskeleton robots are transitioning from experimental artifacts into operational tools that promise measurable benefits for mobility, rehabilitation, and workforce protection. This transition requires more than incremental hardware improvements; it demands integrated strategies that align engineering choices with clinical evidence, procurement structures, and regional regulatory realities. When organizations adopt a systems perspective-covering product modularity, service readiness, and supply chain resilience-they reduce deployment risk and increase the likelihood of realizing the anticipated outcomes of reduced injury rates, improved patient recovery trajectories, or enhanced operational capability.

Looking ahead, success will be determined by the ability to generate credible, repeatable evidence of value and to operationalize devices as part of broader occupational health or clinical pathways. Stakeholders should therefore prioritize collaborative pilots, invest in training infrastructures, and maintain flexibility in sourcing and commercial models to adapt to evolving policy landscapes and technological progress. With careful alignment of technical innovation and pragmatic deployment practices, exoskeleton technologies can move beyond niche pilots to become durable assets across defense, industry, and healthcare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Exoskeleton Robots Market, by Product Type

  • 8.1. Full Body
  • 8.2. Lower Limb
  • 8.3. Upper Limb

9. Exoskeleton Robots Market, by Application

  • 9.1. Defense
    • 9.1.1. Bomb Disposal
    • 9.1.2. Load Carriage
    • 9.1.3. Soldier Augmentation
  • 9.2. Industrial
    • 9.2.1. Manufacturing
    • 9.2.2. Material Handling
    • 9.2.3. Warehousing
  • 9.3. Medical
    • 9.3.1. Rehabilitation
      • 9.3.1.1. Gait Training
      • 9.3.1.2. Physical Therapy
    • 9.3.2. Surgical Assistance
    • 9.3.3. Therapy
  • 9.4. Personal Assistance
    • 9.4.1. Daily Living Support
    • 9.4.2. Mobility Assistance

10. Exoskeleton Robots Market, by End User

  • 10.1. Defense Organizations
  • 10.2. Hospitals
  • 10.3. Manufacturing Facilities
  • 10.4. Rehabilitation Centers

11. Exoskeleton Robots Market, by Technology

  • 11.1. Active
  • 11.2. Passive

12. Exoskeleton Robots Market, by Actuation Mode

  • 12.1. Electric
  • 12.2. Hydraulic
  • 12.3. Pneumatic

13. Exoskeleton Robots Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Exoskeleton Robots Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Exoskeleton Robots Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Exoskeleton Robots Market

17. China Exoskeleton Robots Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Bioness, Inc.
  • 18.6. Bionik Laboratories Corp.
  • 18.7. Cyberdyne Inc.
  • 18.8. Ekso Bionics Holdings, Inc.
  • 18.9. ExoAtlet
  • 18.10. Fourier Intelligence
  • 18.11. Fourier Intelligence Ltd.
  • 18.12. Gogoa Mobility Robots SL
  • 18.13. Honda Motor Co., Ltd.
  • 18.14. Hyundai Motor Company
  • 18.15. INNOPHYS Co., Ltd.
  • 18.16. Levitate Technologies, Inc.
  • 18.17. Lockheed Martin Corporation
  • 18.18. Myomo, Inc.
  • 18.19. Noonee AG
  • 18.20. Ottobock SE & Co. KGaA
  • 18.21. Panasonic Corporation
  • 18.22. Parker-Hannifin Corporation
  • 18.23. ReWalk Robotics Ltd.
  • 18.24. Sarcos Technology and Robotics Corporation
  • 18.25. suitX
  • 18.26. Technaid S.L.
  • 18.27. Wearable Robotics Srl

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXOSKELETON ROBOTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL EXOSKELETON ROBOTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA EXOSKELETON ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY FULL BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY FULL BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY FULL BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY BOMB DISPOSAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY BOMB DISPOSAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY BOMB DISPOSAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY LOAD CARRIAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY LOAD CARRIAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY LOAD CARRIAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY SOLDIER AUGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY SOLDIER AUGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY SOLDIER AUGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MATERIAL HANDLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MATERIAL HANDLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MATERIAL HANDLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY GAIT TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY GAIT TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY GAIT TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY SURGICAL ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY SURGICAL ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DAILY LIVING SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DAILY LIVING SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DAILY LIVING SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MOBILITY ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MOBILITY ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MOBILITY ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MANUFACTURING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MANUFACTURING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY MANUFACTURING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY ELECTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY ELECTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY ELECTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY HYDRAULIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY HYDRAULIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 200. GCC EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. GCC EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 205. GCC EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 206. GCC EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 207. GCC EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 208. GCC EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. GCC EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 233. G7 EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. G7 EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 238. G7 EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 239. G7 EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 240. G7 EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. G7 EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 244. NATO EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. NATO EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 249. NATO EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 250. NATO EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 251. NATO EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. NATO EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL EXOSKELETON ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA EXOSKELETON ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY PERSONAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA EXOSKELETON ROBOTS MARKET SIZE, BY ACTUATION MODE, 2018-2032 (USD MILLION)